Analyst Price Target is $38.80
▲ +94.00% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Mirum Pharmaceuticals in the last 3 months. The average price target is $38.80, with a high forecast of $51.00 and a low forecast of $30.00. The average price target represents a 94.00% upside from the last price of $20.00.
Current Consensus is
The current consensus among 5 contributing investment analysts is to buy stock in Mirum Pharmaceuticals. This Buy consensus rating has held steady for over two years.